Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dosing of Ketorolac Impacts Post-cesarean paiN manaGemenet (KING): A Randomized Controlled Trial

NCT05248984 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT05248984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05248984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dosing of Ketorolac Impacts Post-cesarean paiN manaGemenet (KING): A Randomized Controlled Trial
Lead sponsor
Ohio State University
Phase
Phase 4
Overall status
Completed
Start date
June 8, 2022
Completion date
November 30, 2023
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post cesarean pain